A father-son legacy of Padma honors and pioneering scientific research
Written by Siddhi Patil,
Dr Chetan Eknath Chitnis, a globally renowned Indian scientist, has dedicated his life to combating malaria, a persistent global health challenge claiming countless lives annually. His groundbreaking work in malaria vaccine development has earned him the prestigious Padma Shri this year, alongside awards like the Shanti Swarup Bhatnagar Award and the Infosys Prize. Remarkably, Dr. Chitnis shares a rare distinction with his father, Eknath Vasant Chitnis, a Padma Bhushan recipient (1985) and a founding member of the Indian Space Research Organisation (ISRO). This rare father-son duo's Padma honors reflect a deep family legacy of scientific excellence, with both making transformative contributions to their respective fields.
Dr. Chitnis's journey in medical research is deeply rooted in his upbringing. His father, a distinguished space scientist and former director of ISRO's Space Application Centre, instilled a passion for dedicated work. 'My father taught me that true commitment means loving what you do, no matter the hours,' Dr. Chitnis recalls. While he initially pursued physics, inspired by his father's rigor, it was his mother, a biochemist focused on cancer research, who steered him toward biology. This pivot led him to lead the Malaria Parasite Biology and Vaccines Unit at Institut Pasteur in Paris, where he drives innovative vaccine research to curb malaria's devastating impact.
Pune holds a special place in Dr. Chitnis's heart. Childhood summers spent at his grandparents' home in Deccan Gymkhana, exploring nearby hills with cousins, evoke memories of a serene, green Pune. His parents' decision to settle in the city post-retirement deepened his connection. Today, as Pune evolves into a bustling hub of innovation, Dr. Chitnis is eager to engage with its academic and research communities, blending personal nostalgia with professional aspirations.
From IIT Bombay to UC Berkeley, the National Institutes of Health, and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi, Dr. Chitnis's career spans continents. His work at ICGEB, supported by robust government backing, laid the foundation for his current efforts in Paris. A significant breakthrough came during the COVID-19 pandemic when delayed vaccine trials at Oxford revealed that a 14-month gap between doses reduced malaria parasite growth—an unexpected finding inspired by similar COVID-19 vaccine insights. This discovery, coupled with advancements in mRNA technology, fuels his cautious optimism for future malaria solutions.
The Padma Shri holds deep significance for Dr. Chitnis. 'Being recognised by my homeland, even after a decade abroad, is humbling,' he says. He views the award as a tribute to his team's collective efforts and a call to continue serving society.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
26 minutes ago
- Time of India
Indian astronaut Shubhanshu Shukla's space mission's schedule out: Check launch date, arrival time, and how to watch live
Axiom Mission 4, carrying ISRO astronaut Shubhanshu Shukla, is set to launch to the ISS on June 10. NASA, Axiom Space, and SpaceX are targeting a launch at 8:22 a.m. EDT. This mission marks the first time an Indian astronaut will visit the ISS as part of a collaboration between NASA and ISRO, fulfilling a commitment to advance space collaboration. Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein. More
Time of India
26 minutes ago
- Time of India
Maharashtra reports 114 new COVID-19 cases; one more patient dies
As many as 114 new COVID-19 cases were reported in Maharashtra, taking the count to 1,276 since January this year, while one more patient succumbed to the infection, pushing up the toll to 18, the state health department said on Friday. Of these cases, 44 were detected in Pune (42 in civic limits in two in rural areas), 37 in Mumbai and seven each in Mira Bhayandar and Panvel Municipal Corporation areas. They were followed by civic areas of Navi Mumbai (4), Pimpri-Chinchwad (6), Kalyan (3), Thane, Satara, Kolhapur, Sangli, Chatrapati Sambhajinagar and Parbhani (one case each), a health department statement said. The department has conducted 15,510 COVID-19 tests since January, of which 1,276 were reported positive, it said. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo Meanwhile, the total number of cases in Mumbai since January stood at 612, most of them were recorded in May, it said. One more patient has died since Thursday, taking the toll to 18. Of these, 17 patients suffered from comorbidities (simultaneous presence of two or more medical conditions), said the department. Live Events Meanwhile, Thane and Kalyan-Dombivli civic corporations released separate data and reported nine new COVID-19 cases in areas under jurisdiction. The number of active patients currently receiving treatment or under home observation across both civic bodies stood at 38, according to official data released by Thane and Kalyan-Dombivli municipal corporations. The Thane Municipal Corporation (TMC) registered 6 new cases, bringing the city's total case count to 137 since the beginning of the latest outbreak. In an official release, the TMC stated, "So far, 107 patients have been discharged, while the number of persons admitted to hospitals stood at 11. The city has registered one death so far." The neighbouring Kalyan-Dombivli Municipal Corporation (KDMC), in a separate release, said three new COVID-19 patients were detected in civic areas, taking the tally so far to 18. The death toll remained unchanged at three, it added.
News18
an hour ago
- News18
A Very 'Civil' Engineer: IISc Professor Madhavi Latha Spent 17 Years Building Chenab Bridge
Last Updated: Professor Latha's team adopted a 'design-as-you-go' philosophy, continuously adapting and innovating in real time Inaugurated by Prime Minister Narendra Modi in Jammu and Kashmir on Friday, the Chenab Bridge, a remarkable feat of Indian engineering, stands as the world's highest such arch bridge. While the project's success is attributable to many, a significant contribution to its structural integrity and stability is from Professor G Madhavi Latha from the Indian Institute of Science (IISc), Bengaluru. Her expertise in rock engineering proved indispensable over 17 years of dedicated involvement. Dr Madhavi Latha, a distinguished geotechnical and rock engineering specialist from IISc's civil engineering department, was specifically enlisted by Northern Railways and the project contractor, Afcons Infrastructure, to address the exceptionally challenging terrain. The bridge spans a deep gorge in the seismically active and geologically complex Himalayan region, where steep slopes, varied rock conditions, and high wind speeds presented formidable obstacles. Dr Latha's primary role was to consult on slope stabilisation and bridge foundation design. Constructing the bridge's massive arch abutments and piers on the steep, often unstable, rock slopes posed immense challenges. During excavation, engineers frequently encountered unforeseen geological conditions, such as fractured rocks, hidden cavities, and varying rock properties, not apparent during initial surveys. Professor Latha's team adopted a 'design-as-you-go" philosophy, continuously adapting and innovating in real time. This involved complex calculations and design modifications to accommodate the actual rock mass conditions encountered during excavation. Her contributions included advising on techniques like cement grouting (injecting cement into rock joints for reinforcement) and the precise design and placement of rock anchors to enhance stability. These measures ensured the foundations could withstand extreme conditions, including high wind forces and seismic activity. The cumulative length of rock anchors used, tens of thousands of metres, testifies to the scale of the challenge. Madhavi Latha's 17-year commitment, from the planning stages in 2005 through the completion of trials in 2022, was crucial in overcoming the unique geotechnical challenges posed by the project's location. Her work ensured that the Chenab Bridge is not only the world's highest but also robust enough to withstand the harsh Himalayan environment for an estimated 120 years. (With agency inputs)
